Oculis Holding AG (OCS)
NASDAQ: OCS · Real-Time Price · USD
27.67
+0.54 (2.01%)
Apr 14, 2026, 12:30 PM EDT - Market open
Oculis Holding AG Market Cap
Oculis Holding AG has a market cap or net worth of $1.64 billion as of April 14, 2026. Its market cap has increased by 57.26% in one year.
Market Cap
1.64B
Enterprise Value
1.34B
1-Year Change
57.26%
Ranking
Category
Stock Price
$27.67
Market Cap Chart
Since May 18, 2021, Oculis Holding AG's market cap has increased from $159.07M to $1.64B, an increase of 929.08%. That is a compound annual growth rate of 60.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 1.62B | 39.93% |
| Dec 31, 2025 | 1.15B | 61.89% |
| Dec 31, 2024 | 713.06M | 73.50% |
| Dec 29, 2023 | 411.00M | 148.15% |
| Dec 30, 2022 | 165.63M | 4.23% |
| Dec 28, 2021 | 158.90M | -0.10% |
| May 18, 2021 | 159.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sionna Therapeutics | 1.70B |
| Trevi Therapeutics | 1.69B |
| Harmony Biosciences Holdings | 1.67B |
| Nurix Therapeutics | 1.66B |
| Rapport Therapeutics | 1.63B |
| Intellia Therapeutics | 1.59B |
| Nuvation Bio | 1.58B |
| Immunocore Holdings | 1.57B |